Dendritic Cell-based Immunotherapy in Treatment Gastric Cancer

NCT03410732 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

LanZhou University